OPTIKIRA
OptiKira develops novel therapeutics intended to prevent cell death. It targets UPR and regulates its activity to prevent cell degeneration in idiopathic pulmonary fibrosis, nonalcoholic steatohepatitis, diabetes, cancer,, and various neurodegenerative diseases, enabling medical practitioners to treat Retinitis pigmentosa, amyotrophic lateral sclerosis, and other chronic diseases. OptiKira was founded in 2014 and is headquartered in Cleveland, Ohio.
OPTIKIRA
Industry:
Eyewear Health Care Medical Therapeutics
Founded:
2014-01-01
Address:
Cleveland, Ohio, United States
Country:
United States
Website Url:
http://www.optikira.com
Total Employee:
1+
Status:
Active
Contact:
(216)455-3216
Email Addresses:
[email protected]
Total Funding:
8.25 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager Content Delivery Network Global Site Tag Euro Typekit Squarespace Squarespace Add To Cart
Similar Organizations
Avivomed
Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs.
Elicio Therapeutics
Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
Enchroma
EnChroma develops eyewear for color blind people to improve human color vision.
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Kaio Therapy
Kaio Therapy develops a novel hyperthermia system that delivers controlled heat at the cellular level within a tumor.
Oncology Therapeutics Network
Oncology Therapeutics Network
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Symbiotix Biotherapies
Symbiotix Biotherapies is a provider of a novel class of molecular therapeutics intended to develop molecules.
Theradaptive
Theradaptive develops targeted therapeutics using its proprietary THX1 platform
Viking Therapeutics
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
Current Employees Featured
Founder
Official Site Inspections
http://www.optikira.com
- Host name: 104.21.5.201
- IP address: 104.21.5.201
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "OptiKira"
OptiKira - Crunchbase Company Profile & Funding
OptiKira develops novel therapeutics intended to prevent cell death. It targets UPR and regulates its activity to prevent cell degeneration in idiopathic pulmonary fibrosis, nonalcoholic …See details»
OptiKira Company Profile | Management and Employees List
OptiKira Profile and History . OptiKira was formed in 2015 by BioMotiv, the for-profit drug development accelerator of The Harrington Project for Discovery & Development, the …See details»
OptiKira Company Profile - Office Locations, Competitors ... - Craft
OptiKira is a biotechnology company developing drugs that inhibit the unfolded protein response (UPR). It offers therapeutics that target UPR and regulate its activity to prevent cell …See details»
Optikica.com – Vaša online optika | Prodavnica kontaktnih sočiva i ...
OPTIKICA DOO Vojvode R. Putnika 10a, Pančevo Telefon: 066/ 047 121 Email: [email protected] www.optikica.com. Mesečna kontaktna sočiva; Dnevna kontaktna sočiva; …See details»
OptiKira - Contacts, Employees, Board Members, Advisors & Alumni
OptiKira develops novel therapeutics intended to prevent cell death.See details»
Optikira Company Profile 2024: Valuation, Funding & Investors
Optikira General Information Description. Developer of novel therapeutics designed to prevent cell death. The company's therapeutics target cellular unfolded protein responses and regulate …See details»
OptiKira - Org Chart, Teams, Culture & Jobs - The Org
View OptiKira's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
OptiKira - Overview, News & Similar companies | ZoomInfo.com
Jan 9, 2020 Who is OptiKira. OptiKira was formed in 2015 by BioMotiv, the for-profit drug development accelerator of The Harrington Project for Discovery & Development, the Uni …See details»
OptiKira - Company Profile - Tracxn
Nov 30, 2024 OptiKira - Develop therapeutics to prevent cell death that causes retinitis pigmentosa, diabetes, and amyotrophic lateral sclerosis (ALS). This company is not active …See details»
OptiKira - VentureRadar
Similar Companies: Amylyx Pharmaceutical USA Publicly Traded Amylyx is developing a novel therapeutic for Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases …See details»
Optikica - Facebook
Optikica. 2,645 likes · 5 talking about this. Optika sa najpovoljnijim kontaktnim sočivima. Svi vodeći svetski brendovi na jednom mestu.See details»
O nama – Optikica.com
Optikica.com je internet prodavnica kontaktnih sočiva, osnovana sa idejom da je digitalizacija budućnost, a kupovina iz udobnosti vašeg doma i dostava na kućnu adresu veći komfor …See details»
Optikica - Kontaktna sočiva svetskih brendova po... - Facebook
Kontaktna sočiva svetskih brendova po najpovoljnijim cenama. Brza isporuka na vašu adresu. www.optikica.comSee details»
Optikira LLC - Drug pipelines, Patents, Clinical trials - Synapse
Explore Optikira LLC with its drug pipeline, therapeutic area, technology platform, 1 news, Disease Domain:Neoplasms, Nervous System Diseases, Endocrinology and Metabolic …See details»
Optikica - Vaša online optika. Kontaktna sočiva svetskih... - Facebook
Vaša online optika. Kontaktna sočiva svetskih brendova po najpovoljnijim cenama. Brza i sigurna isporuka na vašu adresu. www.optikica.comSee details»
What is Optikira? Company Culture, Mission, Values | Glassdoor
See what employees say it's like to work at Optikira. Salaries, reviews, and more - all posted by employees working at Optikira.See details»
OptiKira, a New Biotech Start-up, Created to Develop Drugs to …
Feb 2, 2015 OptiKira, a New Biotech Start-up, Created to Develop Drugs to Prevent Cell Death Caused by the Unfolded Protein Response Launched by BioMotiv, the University of California, …See details»
Biomedics 55 mesečna sočiva (3 sočiva) – Optikica.com
OPTIKICA DOO Vojvode R. Putnika 10a, Pančevo Telefon: 066/ 047 121 Email: [email protected] www.optikica.com. Mesečna kontaktna sočiva; Dnevna kontaktna sočiva; …See details»
Avaira Vitality toric mesečna sočiva (3 sočiva) – Optikica.com
OPTIKICA DOO Vojvode R. Putnika 10a, Pančevo Telefon: 066/ 047 121 Email: [email protected] www.optikica.com. Mesečna kontaktna sočiva; Dnevna kontaktna sočiva; …See details»
ColorVUE RAYA mesečna sočiva u boji (2 sočiva) – Optikica.com
OPTIKICA DOO Vojvode R. Putnika 10a, Pančevo Telefon: 066/ 047 121 Email: [email protected] www.optikica.com. Mesečna kontaktna sočiva; Dnevna kontaktna sočiva; …See details»